These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36694613)

  • 1. Multisystem Inflammatory Syndrome therapies in children (MISTIC): A randomized trial.
    Jain S; He F; Brown K; Burns JC; Tremoulet AH
    Contemp Clin Trials Commun; 2023 Apr; 32():101060. PubMed ID: 36694613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing sequential and concurrent treatment regimens in a small n sequential, multiple assignment, randomized trial (snSMART) in the MISTIC study.
    Cheng Y; Tremoulet A; Burns J; Jain S
    J Biopharm Stat; 2023 Dec; ():1-19. PubMed ID: 38095587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment.
    Abdel-Haq N; Asmar BI; Deza Leon MP; McGrath EJ; Arora HS; Cashen K; Tilford B; Charaf Eddine A; Sethuraman U; Ang JY
    Eur J Pediatr; 2021 May; 180(5):1581-1591. PubMed ID: 33452570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
    Velusamy Y; Vivekanandan G; Romli MH; Shankar A; Karuppiah T; Yubbu P
    Turk J Pediatr; 2023; 65(5):719-738. PubMed ID: 37853964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
    Dizon BLP; Redmond C; Gotschlich EC; Sule S; Ronis T; Vazzana KM; Sherman MA; Connor R; Bosk A; Dham N; Harahsheh AS; Wells E; DeBiasi R; Srinivasalu H
    Pediatr Rheumatol Online J; 2023 Jul; 21(1):76. PubMed ID: 37525200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multisystem Inflammatory Syndrome in Children (MIS-C).
    Patel JM
    Curr Allergy Asthma Rep; 2022 May; 22(5):53-60. PubMed ID: 35314921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy.
    Mohri Y; Shimizu M; Fujimoto T; Nishikawa Y; Ikeda A; Matsuda Y; Wada T; Kawaguchi C
    IDCases; 2022; 28():e01493. PubMed ID: 35382510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Use of Anakinra in Multisystem Inflammatory Syndrome During COVID-19 Pandemic.
    Della Paolera S; Valencic E; Piscianz E; Moressa V; Tommasini A; Sagredini R; Kiren V; Comar M; Taddio A
    Front Pediatr; 2020; 8():624248. PubMed ID: 33708752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Evidence on Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection: a Systematic Review with Meta-analysis.
    Sood M; Sharma S; Sood I; Sharma K; Kaushik A
    SN Compr Clin Med; 2021; 3(1):38-47. PubMed ID: 33432304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for multi-system inflammatory syndrome in children - discharge, fever, and second-line therapies.
    Tagarro A; Domínguez-Rodríguez S; Mesa JM; Epalza C; Grasa C; Iglesias-Bouzas MI; Fernández-Cooke E; Calvo C; Villaverde S; Torres-Fernández D; Méndez-Echevarria A; Leoz I; Fernández-Pascual M; Saavedra-Lozano J; Soto B; Aguilera-Alonso D; Rivière JG; Fumadó V; Martínez-Campos L; Vivanco A; Pilar-Orive FJ; Alcalá P; Ruiz B; López-Machín A; Oltra M; Moraleda C;
    Eur J Pediatr; 2023 Jan; 182(1):461-466. PubMed ID: 36282324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19: A retrospective cohort analysis from 28 U.S. Hospitals.
    Harthan AA; Nadiger M; McGarvey JS; Hanson K; Gharpure VP; Bjornstad EC; Chiotos K; Miller AS; Reikoff RA; Gajic O; Kumar V; Walkey AJ; Kashyap R; Tripathi S;
    Pharmacotherapy; 2022 Jul; 42(7):529-539. PubMed ID: 35661394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Treatments for Multisystem Inflammatory Syndrome in Children (MIS-C), United States, February 2020 - July 2021.
    Abrams JY; Belay ED; Godfred-Cato S; Campbell AP; Zambrano LD; Kunkel A; Miller AD; Wu MJ; Meng L; Shah AB; Oster ME
    Clin Infect Dis; 2022 Sep; 75(7):1201-1209. PubMed ID: 35100610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies.
    Tang Y; Li W; Baskota M; Zhou Q; Fu Z; Luo Z; Shi Y; Chen Y; Liu E
    Transl Pediatr; 2021 Jan; 10(1):121-135. PubMed ID: 33633944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national study.
    Licciardi F; Covizzi C; Dellepiane M; Olivini N; Mastrolia MV; Lo Vecchio A; Monno V; Tardi M; Mauro A; Alessio M; Filocamo G; Cattalini M; Taddio A; Caorsi R; Marseglia GL; La Torre F; Campana A; Simonini G; Ravelli A; Montin D
    Front Pediatr; 2023; 11():1137051. PubMed ID: 37675397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland.
    Fouriki A; Fougère Y; De Camaret C; Blanchard Rohner G; Grazioli S; Wagner N; Relly C; Pachlopnik Schmid J; Trück J; Kottanatu L; Perez E; Perez MH; Schaffner D; Asner SA; Hofer M
    Front Pediatr; 2020; 8():594127. PubMed ID: 33469522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
    Burns JC; Roberts SC; Tremoulet AH; He F; Printz BF; Ashouri N; Jain SS; Michalik DE; Sharma K; Truong DT; Wood JB; Kim KK; Jain S;
    Lancet Child Adolesc Health; 2021 Dec; 5(12):852-861. PubMed ID: 34715057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisystem inflammatory syndrome in adults: A rare sequela of SARS-CoV-2 infection.
    Ahmad F; Ahmed A; Rajendraprasad SS; Loranger A; Gupta S; Velagapudi M; Vivekanandan R; Nahas JA; Plambeck R; Moore D
    Int J Infect Dis; 2021 Jul; 108():209-211. PubMed ID: 34044140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-Laboratory Profile, Intensive Care Needs and Short-Term Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C): Experience during First and Second Waves from North India.
    Angurana SK; Kumar V; Nallasamy K; Kumar MR; Naganur S; Kumar M; Goyal K; Ghosh A; Bansal A; Jayashree M
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36048462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.